Issue Date: April 19, 2010
Sanofi Pasteur, Navy Combat Diarrhea
Sanofi Pasteur, the vaccines division of Sanofi-Aventis, will partner with the U.S. Naval Medical Research Center to develop a new bacterial vaccine against enterotoxigenic Escherichia coli (ETEC), a bacterium that causes nearly 400,000 childhood deaths in the developing world and is well-known as the cause of traveler's diarrhea. Under the terms of the four-year research pact, NMRC has licensed two ETEC adhesion vaccine technologies to Sanofi Pasteur, including one with a . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society